Medicare Open Enrollment Brings Major Drug and Coverage Changes
Significant shifts in prescription drug plans and Medicare Advantage networks make this fall's open enrollment period unusually consequential for beneficiaries.
Medicare beneficiaries face an especially critical open enrollment period this fall, with sweeping changes to prescription drug coverage and Medicare Advantage provider networks that could substantially raise out-of-pocket costs for millions of Americans.
Plan administrators are sending notices detailing alterations to formularies — the lists of drugs a plan will cover — as well as shifts in which doctors, hospitals, and specialists fall within network boundaries. Experts urge enrollees not to discard those mailings, as the details they contain could determine whether a current plan remains financially viable for the coming year.
Read more Medicare Open Enrollment 2024: Why This Year Demands Extra Attention →
Medicare Advantage, the privately administered alternative to traditional Medicare, has seen particularly notable network restructuring in recent cycles. Beneficiaries who fail to review their plan's annual notice of change risk finding that a preferred physician or specialist is no longer covered at the same cost-sharing level, or at all.
Prescription drug plan dynamics have also shifted markedly, partly as a result of federal policy changes affecting how drug costs are structured under Medicare Part D. Premiums, deductibles, and the drugs covered at various tiers can all change from year to year, meaning a plan that offered good value in 2024 may not do so in 2025.
Financial advisers and Medicare counselors consistently recommend that enrollees use the federal government's Medicare Plan Finder tool to compare options side by side before the open enrollment deadline. Choosing not to shop could mean paying more for the same or reduced coverage. Continue reading at NYT > Business.
